Analyst Highlights Technical Setups for JSW Steel, Anthem Biosciences, eClerx

BROKERAGE-REPORTS
Whalesbook Logo
AuthorIshaan Verma|Published at:
Analyst Highlights Technical Setups for JSW Steel, Anthem Biosciences, eClerx

With Nifty 50 facing volatility near 24,200, analyst Raja Venkatraman has identified technical patterns in JSW Steel, Anthem Biosciences, and eClerx. These observations focus on tactical price levels for the September series, though investors should account for broader market trends and the specific operational risks associated with these sectors.

Indian equity markets are currently navigating a period of uncertainty, with the Nifty 50 and BSE Sensex struggling to maintain momentum near critical resistance levels. As of late August 2026, the Nifty 50 has faced selling pressure near 24,300, forcing traders to closely watch support zones to gauge the next trend. In this environment, technical analyst Raja Venkatraman of NeoTrader has highlighted three stocks—JSW Steel, Anthem Biosciences, and eClerx—that are displaying specific price patterns.

Technical Observations and Company Context

JSW Steel Limited remains a closely watched stock due to its weight in the steel sector and its manufacturing-heavy business model. The analyst noted technical activity near its moving averages, which often draws interest from tactical traders. Investors monitoring JSW Steel should consider that the company’s performance is frequently linked to broader industrial demand and global commodity prices. While technical setups may suggest short-term momentum, the stock's long-term health typically depends on execution in its expansion projects and the stability of steel realizations.

Anthem Biosciences Limited, which listed on Indian exchanges in 2025, represents the pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization) space. Because the company is a relatively newer entrant to the public markets, its stock can be more sensitive to volatility compared to long-standing industry peers. The business model relies on global pharmaceutical clients, making it vulnerable to shifts in research budgets and regulatory outcomes, such as USFDA approvals. Technical breakouts in such stocks are often treated as tactical signals rather than indicators of long-term stability.

eClerx Services Limited, a firm focused on business process management and data analytics, was also highlighted for its price consolidation patterns. The company operates in the services sector, where revenue is tied to the discretionary spending of global clients. Unlike manufacturing companies, eClerx is less capital-intensive but faces competition from both large IT players and niche firms. Its stock movement is often driven by earnings growth visibility and client retention rates, which remain key fundamental monitorables beyond any technical price action.

Risks and Market Reality

It is important for investors to distinguish between technical trading setups and the underlying business risks of these companies. Technical strategies are designed for short-term tactical positions and often carry significant risk, particularly when market-wide volatility, such as the current fluctuations in the Nifty 50, leads to sudden stop-loss triggers.

Furthermore, each stock faces distinct sector pressures. JSW Steel is sensitive to raw material cost inflation, Anthem Biosciences must navigate the complex regulatory and client-retention landscape of the pharma sector, and eClerx remains exposed to global economic trends that affect IT services. Investors looking at these setups should prioritize whether these tactical opportunities align with their risk appetite and time horizon. The next important step for the market will be the performance of the Nifty 50 around the 24,000–24,300 range, as this will likely dictate the broader confidence for sector-specific plays.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.